 |
|
|
| |
Safety, efficacy and tolerability in the treatment of patients
with Chronic Hepatitis C and Severe Renal Impairment
|
| |
| |
Reported by Jules Levin
AASLD 2015 Nov 13-17 San Francisco
Frank Czul, Adam Peyton, Christopher O'Brien, Lennox J. Jeffers, Paul Martin, Kalyan R. Bhamidimarri
1Division Hepatology, University of Miami Miller School of Medicine 2Division of Nephrology, University of Miami Miller School of Medicine
|
| |
|
|
|
|
|
